Bachem Holding AG (BCHMF)

Market Cap	5.54B +18.3%
Revenue (ttm)	852.45M +17.3%
Net Income	168.74M +18.2%
EPS	2.26 +18.5%
Shares Out	n/a
PE Ratio	32.85
Forward PE	29.13
Dividend	1.03 (1.24%)
Ex-Dividend Date	May 5, 2025

Volume	120
Average Volume	693
Open	76.77
Previous Close	n/a
Day's Range	76.77 - 76.77
52-Week Range	60.51 - 82.73
Beta	1.07
RSI	44.00
Earnings Date	Mar 12, 2026

About Bachem Holding AG

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, an...

• Industry: Chemicals
• Sector: Materials
• Founded: 1971
• Employees: 2,292
• Stock Exchange: OTCMKTS
• Ticker Symbol: BCHMF

Financial Performance

In 2024, Bachem Holding AG's revenue was 605.26 million, an increase of 4.84% compared to the previous year's 577.32 million. Earnings were 120.25 million, an increase of 7.50%.

Financial numbers in CHF